Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | MPI | P34949 | 1/20 | 0.46 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.38 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | HTT | P42858 | 3/20 | 0.38 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11884135 | 0.90 | SMN1; SMN2 (0.81) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL11737155 | 0.80 | CYP1A2 (0.65) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL11735227 | 0.78 | SMN1; SMN2 (0.62) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL11736694 | 0.78 | SMN1; SMN2 (0.62) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL2826648 | 0.78 | SMN1; SMN2 (0.64) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL11733666 | 0.77 | SMN1; SMN2 (0.61) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL11732378 | 0.77 | SMN1; SMN2 (0.61) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL11738041 | 0.76 | SMN1; SMN2 (0.61) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL11743012 | 0.76 | SMN1; SMN2 (0.59) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| Niridazole SCHEMBL27347458 | 0.75 | SMN1; SMN2 (0.59) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1593 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4586826-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | In the Bowl Animal Health, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| CN-114071074-B | Picture acquisition, processing and display method and system for Beidou No. three short message channel | 武汉兴图新科电子股份有限公司 | 2024-12-24 | — | — | CN | claimed |
| US-20240173512-A1 | METHODS FOR POTENTIATING ANTIMICROBIAL AGENTS | STREETERVILLE CAPITAL, LLC | 2024-05-30 | — | — | US | claimed |
| WO-2024059837-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | IN THE BOWL ANIMAL HEALTH, INC. (US) | 2024-03-21 | — | — | WO | claimed |
| US-11890421-B2 | Methods for potentiating antimicrobial agents | BEYOND AIR LTD (IL) | 2024-02-06 | — | — | US | claimed |
| CN-114071074-A | Method and system for acquiring, processing and displaying picture of Beidou No. three short message channel | 武汉兴图新科电子股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| US-20200246573-A1 | NITRIC OXIDE INHALATION THERAPY FOR INFANTS WITH BRONCHIOLITIS | STREETERVILLE CAPITAL, LLC | 2020-08-06 | — | — | US | claimed |
| US-20190142817-A1 | COMPOSITIONS AND METHODS FOR DRUG SENSITIZATION OF PARASITES | THE TEXAS A&M UNIVERSITY SYSTEM | 2019-05-16 | — | — | US | claimed |
| EP-3078664-B1 | ANTIPARASITIC DIHYDROAZOLE COMPOSITIONS | MERIAL INC (US) | 2019-02-20 | — | — | EP | claimed |
| US-20050246023-A1 | Disc shunt for treating back pain | YEUNG JEFFREY E | 2005-11-03 | — | — | US | claimed |
| EP-0507629-B1 | Sustained release capsule and formulations for insertion into rumen | LILLY CO ELI (US) | 1997-01-22 | — | — | EP | claimed |
| US-5567434-A | DISSOLVING COMPOUND AND LIPID IN APROTIC SOVENT, EXTRUDING INTO AQUEOUS SOLUTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-10-22 | — | — | US | claimed |
| EP-0467954-B1 | PREPARATION OF LIPOSOME AND LIPID COMPLEX COMPOSITIONS | UNIV CALIFORNIA (US) | 1996-05-01 | — | — | EP | claimed |
| US-5277914-A | Encapsulation in non-halogenated aprotic solvent | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-01-11 | — | — | US | claimed |
| US-5277912-A | Sustained release capsule and formulations | ELI LILLY AND COMPANY (US) | 1994-01-11 | — | — | US | claimed |
| US-5232441-A | Method of treating schistosomal infestations by iontophoresis | PHYSION S.R.L. (IT) | 1993-08-03 | — | — | US | claimed |
| EP-0507629-A1 | Sustained release capsule and formulations for insertion into rumen | ELI LILLY AND COMPANY (US) | 1992-10-07 | — | — | EP | claimed |
| US-5077057-A | Dissolving in aprotic solvent; extrusion into aqueous solution | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1991-12-31 | — | — | US | claimed |
| EP-0305968-A2 | Compositions against protozoal diseases | YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) | 1989-03-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190142817-A1 | COMPOSITIONS AND METHODS FOR DRUG SENSITIZATION OF PARASITES | ABCC1, SLC11A2, ABCB11 | SMN1; SMN2 4266/4885CYP1A2 441/4885CYP3A4 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.